Reduced ‐intensity conditioning allogeneic transplantation after salvage treatment with DT‐PACE in myeloma patients relapsing early after autologous transplant

ConclusionReduced‐intensity alemtuzumab‐conditioned allograft for myeloma after DT‐PACE salvage chemotherapy is an efficient and low toxicity treatment for those who had a suboptimal response postautologous stem cell transplant for myeloma.

Source: European Journal of Haematology - July 20, 2017 Category: Hematology Authors: Kate Randall, Maria Kaparou, Evgenia Xenou, Shankara Paneesha, Bhuvan Kishore, Alexandros Kanellopoulos, Richard Lovell, Kathy Holder, Julie Suhr, Lynda Baker, Lynn Ryan, Emmanouil Nikolousis Tags: ORIGINAL ARTICLE Source Type: research